Claude discovers a novel enzyme system with CRISPR-like repeats
Thread
Unofficial Hacker News client; not affiliated with Y Combinator.
Claude discovers a novel enzyme system with CRISPR-like repeats
Unofficial Hacker News client; not affiliated with Y Combinator.
modeless · · focus · HN ↗
No doubt that curing cancer would help, but I think the timeline might be a little too long. Even RSI AGI will not be able to get new medical treatments to market instantly. Real world testing takes a long time and is an unavoidable part of the process.
JoeOfTexas · · focus · HN ↗
Aboutplants · · focus · HN ↗
toomuchtodo · · focus · HN ↗
D-Machine · · focus · HN ↗
victorbjorklund · · focus · HN ↗
jobs_throwaway · · focus · HN ↗
SpicyLemonZest · · focus · HN ↗
smolder · · focus · HN ↗
dekhn · · focus · HN ↗
asdff · · focus · HN ↗
D-Machine · · focus · HN ↗
sourcinnamon · · focus · HN ↗
<a href="https://www.cancer.gov/news-events/cancer-currents-blog/2024/fda-amtagvi-til-therapy-melanoma" rel="nofollow">https://www.cancer.gov/news-events/cancer-currents-blog/2024...
<a href="https://jitc.bmj.com/content/8/2/e000848" rel="nofollow">https://jitc.bmj.com/content/8/2/e000848 (careful: Figure 1 can be very graphical, but it shows the huge positive impact of this therapy)
We also have therapies based on monoclonal recombinant antibodies conjugated with chemotherapeutics. Simply put, we can produce antibodies that are specific for markers present in the surface of cancer cells, and we can attach drugs that can kill those cells. The antibody part is what makes this type of therapy very effective (you target only cancer cells, and not healthy cells) and also very expensive.
D-Machine · · focus · HN ↗
Also, we barely have more than 3 years data for CAR-T for most cancers. And even still, the survival rates aren't great, in many cases 50% compared to e.g. <20% for previous chemo-immunotherapies plus marrow transplants. And this ignores how massively immunocompromised CAR-T leaves you (for at least a year in close to half of cases, but maybe even permanently, in perhaps as high as 10% of cases, at least for some lymphomas).
I say this as a person that is only alive because of CAR-T treatment 1.5 years ago.
ransom1538 · · focus · HN ↗
Glyptodon · · focus · HN ↗